Udo Vanhoefer, MD | Authors

Oral Fluoropyrimidine-Based Combination Therapy in Gastrointestinal Cancer

January 02, 2001

Significant emphasis has been placed recently on designing more effective fluorouracil (5-FU)-based combination protocols for gastrointestinal cancer. Promising results were seen with 5-FU/leucovorin in combination with